Coronavirus Clinical Trials 2024

Coronavirus Clinical Trials 2024

Coronavirus research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in coronavirus clinical trials today.

Coronavirus Clinical Trials

Here are the 6 most popular medical studies for coronavirus

Popular filter options for coronavirus trials

COVID-19 Clinical Trials

View 95 COVID-19 medical studies.

Acute Respiratory Distress Syndrome Clinical Trials

View 7 Acute Respiratory Distress Syndrome medical studies.

Phase 3 Coronavirus Clinical Trials

View 98 phase 3 coronavirus medical studies.

Coronavirus Clinical Trials With No Placebo

View 98 coronavirus medical studies that do not have a placebo group.

Paid Coronavirus Clinical Trials

View 98 coronavirus medical studies that offer remuneration.

View More Coronavirus Trials

See another 68 medical studies focused on coronavirus.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to coronavirus

What are the top hospitals conducting coronavirus research?

As the world continues to grapple with the ongoing COVID-19 pandemic, hospitals are playing a crucial role in conducting clinical trials to find effective treatments and vaccines. Among these institutions is the University of Michigan in Ann Arbor, which has embarked on two active coronavirus trials, marking an important step forward in combating this global crisis. Having recorded its first trial in 2020, the university is dedicated to exploring innovative approaches to tackle the virus head-on. Meanwhile, Grady Health System in Atlanta has one ongoing coronavirus trial underway. While they may not have conducted any previous trials specifically focused on COVID-19, their involvement signifies their commitment to contribute towards finding solutions for this unprecedented health challenge.

In Atlanta itself, other hospitals are also actively engaged in advancing our understanding of and response to COVID-19. Emory University Hospital Midtown has initiated one current coronavirus trial along with having accomplished a single prior investigation since recording its inaugural coronavirus trial in 2020. Similarly, Emory Hospital and Metro-Atlanta each have one active coronavirus trial but do not possess any completed trials at present.

These hospitals’ dedication demonstrates their pivotal roles as centers of research and innovation during these challenging times. Through rigorous scientific exploration and collaboration among medical professionals across diverse locations like Ann Arbor and Atlanta alike, progress is made toward identifying strategies that will ultimately help us overcome this devastating global pandemic together

Which are the best cities for coronavirus clinical trials?

When it comes to coronavirus clinical trials, several cities emerge as leaders in research and development. Atlanta, Georgia, Houston, Texas, Toronto, Ontario, New york City, and Washington D.C. are among the top locations with active trials. These cities offer individuals access to studies focusing on various treatments such as LDN Treatment Arm and 9vHPV Vaccine in Atlanta; Niclosamide and 700mg Leronlimab in Houston; VBI-2901a and Aspirin Treatment in Toronto; Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG) and Stress First Aid in New York City; Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)and 9vHPV Vaccine in Washington D.C. By conducting these trials across different regions, researchers aim to advance our understanding of potential treatment options for COVID-19.

Which are the top treatments for coronavirus being explored in clinical trials?

The race to find effective treatments for the coronavirus continues, with several promising options emerging in clinical trials. Leading the pack is VBI-2901a, currently being tested in one active trial dedicated to fighting this global pandemic. Another contender gaining attention is the 9vHPV vaccine, also undergoing evaluation in one ongoing coronavirus trial. Baricitinib completes the lineup as a potential treatment option, with two all-time trials and one active trial focused on combatting COVID-19 since its first listing in 2020. These innovative therapies offer hope for a brighter future amidst these challenging times.

What are the most recent clinical trials for coronavirus?

Recent clinical trials for coronavirus offer promising prospects in the fight against this global pandemic. These include innovative approaches such as intravenously delivered MSC-exosomes, which are administered every other day on an escalating dose to combat the virus. Additionally, the mRNA-CR-04 vaccine has shown potential in early-phase trials, providing hope for effective immunization strategies. Another trial examines azeliragon's efficacy as a treatment option through its progression from Phase 2 to Phase 3 studies. Furthermore, the mRNA-1045 Dose Level B and VBI-2901a have both entered Phase 1 trials, demonstrating ongoing efforts to discover new therapeutic interventions against coronavirus infection. These cutting-edge clinical investigations signify significant advancements in our collective battle against COVID-19.

What coronavirus clinical trials were recently completed?

Several significant clinical trials for coronavirus have recently reached completion, showcasing the relentless efforts to combat this global health crisis. Notably, in August 2021, Merck Sharp & Dohme Corp. concluded a trial investigating the potential of Molnupiravir as a treatment option. Around the same time, Janssen Vaccines & Prevention B.V.'s trial on Ad26.COV2.S came to an end, examining its efficacy as a vaccine candidate. Additionally, research led by James L. Kirkland explored Fisetin's potential against COVID-19 and was completed in July 2021. These trials represent critical steps forward in our ongoing battle against the pandemic and demonstrate the dedication of researchers worldwide towards finding effective solutions.